ASPN · Aspen Aerogels Inc
Market Cap
$408.30M
Shares
82.99M
ASPN metrics
71 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$4.92
Market cap
$408.30M
Price action
19 metricsPrice change (1W)
-0.2%
Price change (30D)
-28.6%
Price change (3M)
-12.8%
Price change (6M)
+52.8%
Price change (YTD)
+73.9%
Price change (1Y)
-22.5%
Trailing year
Price change (5Y)
-88.9%
52-week high
$8.82
52-week low
$2.57
Change from 52-week high
-44.2%
Change from 52-week low
+91.4%
Annualized volatility
100.5%
Beta
2.1
RSI (14D)
43.5
Price vs SMA 50
-7.2%
Price vs SMA 200
+15.6%
Avg volume (3M)
1.33M
Relative volume
0.3
Average dollar volume
$7.64M
Company
3 metricsSector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
82.99M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.0×
reciprocal yield 49.5%
P / book
2.1
reciprocal yield 47.1%
FCF yield
8.4%
TTM · current market cap
Buyback yield
—
P / FCF
11.9
reciprocal yield 8.4%
P / operating cash flow
8.3
reciprocal yield 12.0%
Earnings yield
-30.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 71.2%
EV / revenue historical average (5Y)
3.3×
reciprocal yield 30.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-06
Profitability
9 metricsGross margin
2.7%
Operating margin
-61.0%
Trailing 12 months
Net margin
-62.4%
Gross profit (TTM)
$5.41M
Operating profit (TTM)
−$123.35M
Net income (TTM)
−$126.20M
Trailing 12 months
Diluted EPS (TTM)
$-1.52
FCF margin
17.0%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-36.1%
Year over year
Net income growth YoY
-3,012.5%
Revenue (TTM)
$202.09M
Trailing 12 months
EPS growth YoY
-2,882.4%
Shares change YoY
+0.9%
Year over year · more shares
Revenue CAGR (3Y)
+14.5%
Revenue CAGR (5Y)
+22.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-65.6%
Return on assets
-32.1%
Debt / equity
0.4
Current ratio
2.5
EBITDA (TTM)
−$1.48M
Free cash flow (TTM)
$34.38M
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$151.71M
Total assets
$392.94M
Total debt
$80.32M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$49.12M
Capital expenditures (TTM)
$14.73M
R&D (TTM)
$11.21M
SG&A (TTM)
—
Stock compensation (TTM)
$7.59M
R&D / revenue
5.5%
Stock compensation / revenue
3.8%
Ownership (13F)
3 metrics13F filers
181
13F filer change QoQ
+12
Institutional ownership
89.2%
Short interest
3 metricsShort interest
9.7%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
55 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1145986
CUSIP
04523Y105
13F (30d)
145 filings
145 filers
Visit website
Investor relations